Health Conditions

Phosphoribosyl Pyrophosphate Synthase-associated Protein 2 Levels

1 variant Other

Phosphoribosyltransferase Domain-containing Protein 1 Levels

1 variant Other

Photobacterium Abundance in Stool

1 variant Other

Physical Activity (principal Component 2)

1 variant Other

Physical Activity (total Log Acceleration 10pm-12am)

1 variant Other

Physical Activity (total Log Acceleration 6am-8am)

1 variant Other

Physical Activity (total Log Acceleration 8am-10am)

1 variant Other

Physical Activity (total Log Acceleration 8pm-10pm)

1 variant Other

Physical Activity (walking Duration)

1 variant Other

Physical Decline (log-difference Score)

1 variant Other

Phytanoyl-coa Hydroxylase-interacting Protein Levels

1 variant Other

Picolinoylglycine (x-12170) Levels

1 variant Other

Pierre Robin Sequence

1 variant Other

Pigment Epithelium-derived Factor (analyte X7735.17) Levels

1 variant Other

Pigment Spots (darkness)

1 variant Other

Pilr Alpha-associated Neural Protein Levels

1 variant Other

Pilr Alpha-associated Neural Protein Levels (pianp.9599.6.3)

1 variant Other

Pilr Alpha-associated Neural Protein Protein Levels (somascan Id:25253-17)

1 variant Other

Pilrb/thbd Protein Level Ratio

1 variant Other

Pilrb/tnfrsf1a Protein Level Ratio

1 variant Other

Pimelylcarnitine Levels

1 variant Other

Piperine Levels

1 variant Other

Pithd1 Protein Levels

1 variant Other

Pituitary Adenylate Cyclase-activating Polypeptide 38 Levels

1 variant Other

Pituitary Adenylate Cyclase-activating Polypeptide Type I Receptor Protein Levels (somascan Id:20539-4)

1 variant Other

Pituitary Homeobox 2 Protein Levels (somascan Id:19556-12)

1 variant Other

Piwi-like Protein 1 Levels

1 variant Other

Pla2g15/smpdl3a Protein Level Ratio

1 variant Other

Pla2g1b/pnliprp2 Protein Level Ratio

1 variant Other

Pla2g4a/spint2 Protein Level Ratio

1 variant Other

Placenta Previa and Abruptio Placenta (phecode 635.3)

1 variant Other

Planococcaceae Abundance in Stool

1 variant Other

Plantar Fascial Disorders

1 variant Other

Plasma Alpha-amino-n-butyric Acid Levels in Alcohol Use Disorder Treated with Acamprosate

1 variant Other

Plasma Amyloid Beta Peptide Concentration (abx-40/abx-42 Ratio)

1 variant Other

Plasma Asparagine Levels in Alcohol Use Disorder Treated with Acamprosate

1 variant Other

Plasma Blast-plasma Cell %b Cell

1 variant Other

Plasma Blast-plasma Cell %lymphocyte

1 variant Other

Plasma Blast-plasma Cell Absolute Count

1 variant Other

Plasma Ethanolamine Levels in Alcohol Use Disorder Treated with Acamprosate

1 variant Other

Plasma Factor V Levels (parent of Origin Effect)

1 variant Other

Plasma Free Asparagine Levels

1 variant Other

Plasma Free Proline Levels

1 variant Other

Plasma Linoleic Acid Percentage of Total Fatty Acids X Fish Oil Supplement Use Interaction (1df)

1 variant Other

Plasma Lysine Levels in Alcohol Use Disorder Treated with Acamprosate

1 variant Other

Plasma Monounsaturated Fatty Acid Levels X Fish Oil Supplement Use Interaction (1df)

1 variant Other

Plasma Neutrophil Extracellular Trap Levels

1 variant Other

Plasma Omega-6 Fatty Acid Percentage of Total Fatty Acids X Fish Oil Supplement Use Interaction (1df)

1 variant Other

Plasma Oxylipin 13-hydroxyoctadecadienoic Acid Levels

1 variant Other

Plasma Oxylipin 9-hydroxylinoleic Acid Levels

1 variant Other

Plasma Protease C1 Inhibitor (analyte X4479.14) Levels

1 variant Other

Plasma Protease C1 Inhibitor Levels (serping1.4479.14.2)

1 variant Other

Plasma Pyridoxal Phosphate Levels

1 variant Other

Plasma Pyridoxic Acid to Pyridoxal Phosphate Ratio

1 variant Other

Plasma Taurine Levels in Alcohol Use Disorder Treated with Acamprosate

1 variant Other

Plasma Tyrosine Levels in Alcohol Use Disorder Treated with Acamprosate

1 variant Other

Plasmin Levels (plg.4150.75.2)

1 variant Other

Plasminogen Activator Inhibitor 1 Levels (serpine1.2925.9.1)

1 variant Other

Plastin-2 (analyte X17231.1) Levels

1 variant Other

Plastin-2 Levels (lcp1.9749.190.3)

1 variant Other